Mark Hlatky, MD
Academic Appointments
- Professor, Health Research & Policy - Health Services Research
- Professor, Medicine - Cardiovascular Medicine
Key Documents
Contact Information
-
Clinical Offices
HRP Redwood Bld Rm 150 MC: 5405 Stanford, CA 94305 Tel Work (650) 723-6426 Fax (650) 725-6951
- Academic Offices
Personal Information Email Tel (650) 723-6426 Tel (650) 723-6428Alternate Contact Elaine Steel EmailNot for medical emergencies or patient use
Professional Overview
Clinical Focus
- Cardiovascular Disease
- Cardiovascular Medicine
Administrative Appointments
- Director, Stanford-Kaiser Cardiovascular Outcomes Research Center (2008 - present)
- Director, Health Services Research Masters Degree Program (1989 - present)
- Chair, Department of Health Research and Policy (1996 - 2003)
Professional Education
| Medical Education: | University of Pennsylvania PA (1976) |
| Board Certification: | Cardiovascular Disease, American Board of Internal Medicine (1983) |
| Fellowship: | Duke University Medical Center NC (1983) |
| Fellowship: | UCSF Medical Center CA (1981) |
| Board Certification: | Internal Medicine, American Board of Internal Medicine (1979) |
| Residency: | University of Arizona College of Medicine AZ (1979) |
Graduate & Fellowship Program Affiliations
Scientific Focus
Current Research Interests
Cardiovascular Health Services Research
Cost-Effective Analysis, especially of new technology
Clinical Outome Research
Randomized Clinical Trials with cost, quality of life endpoints (coronary angioplasty, stents, and bypass surgery; diabetes management)
Clinical Guidelines Development
Patient Outcomes Research in Cardiac Arrhythmias
Publications
- Association of coronary CT angiography or stress testing with subsequent utilization and spending among Medicare beneficiaries. JAMA. 2011; (19): 2128-36
- Cost-effectiveness of using high-sensitivity C-reactive protein to identify intermediate- and low-cardiovascular-risk individuals for statin therapy. Circulation. 2010; (15): 1478-87
- Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet. 2009; (9670): 1190-7
- Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation. 2009; (17): 2408-16
- Economic outcomes of treatment strategies for type 2 diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial. Circulation. 2009; (25): 2550-8
- Statin and beta-blocker therapy and the initial presentation of coronary heart disease. Ann Intern Med. 2006; (4): 229-38
Help